Clinical Trial Update: Study of Sirolimus Versus Mycophenolate Liver Transplant Recipients With Recurrent Hepatitis C Virus (HCV) [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing sirolimus versus mycophenolate in liver transplant recipients with recurrent hepatitis C; results were posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• CELLCEPT (mycophenolate mofetil hydrochloride)
• Rapamune (sirolimus)

Snippet

Sponsor: London Health Sciences Centre | Conditions: Hepatitis C | Phase 4 | Status: COMPLETED | Results posted: 2015-01-21